Here are five key points:
1. The investment banking firm serving as initial purchaser has the option to purchase another $9.75 million aggregate principal amount of notes.
2. The notes will be sold to “qualified institutional buyers.”
3. They will be unsecured, unsubordinated obligations of the company. The notes will have an interest at a rate of 6 percent per year.
4. Bacterin estimates that net proceeds will be about $62.8 million.
5. Bacterin plans to put the net proceeds of the offering towards funding the cash portion of the purchase price of the acquisition of X-spine Systems.
More articles on devices:
Maryland Brain & Spine adds ‘Pain’ to its name: 5 points
InVivo CEO plans big: 5 key notes on capturing the spinal injury market
DJO Global net sales down 1%: 10 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
